358 related articles for article (PubMed ID: 30269490)
1. DARK Classics in Chemical Neuroscience: Aminorex Analogues.
Maier J; Mayer FP; Brandt SD; Sitte HH
ACS Chem Neurosci; 2018 Oct; 9(10):2484-2502. PubMed ID: 30269490
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR.
Rickli A; Kolaczynska K; Hoener MC; Liechti ME
Neurotoxicology; 2019 May; 72():95-100. PubMed ID: 30776375
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).
McLaughlin G; Morris N; Kavanagh PV; Power JD; Twamley B; O'Brien J; Talbot B; Dowling G; Mahony O; Brandt SD; Patrick J; Archer RP; Partilla JS; Baumann MH
Drug Test Anal; 2015 Jul; 7(7):555-64. PubMed ID: 25331619
[TBL] [Abstract][Full Text] [Related]
4. Using internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4'-dimethylaminorex.
Nizar H; Dargan PI; Wood DM
J Med Toxicol; 2015 Mar; 11(1):80-4. PubMed ID: 25167967
[TBL] [Abstract][Full Text] [Related]
5. Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine.
Young R
Pharmacol Biochem Behav; 1992 May; 42(1):175-8. PubMed ID: 1356272
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').
Brandt SD; Baumann MH; Partilla JS; Kavanagh PV; Power JD; Talbot B; Twamley B; Mahony O; O'Brien J; Elliott SP; Archer RP; Patrick J; Singh K; Dempster NM; Cosbey SH
Drug Test Anal; 2014; 6(7-8):684-95. PubMed ID: 24841869
[TBL] [Abstract][Full Text] [Related]
7. Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters.
Hofmaier T; Luf A; Seddik A; Stockner T; Holy M; Freissmuth M; Ecker GF; Schmid R; Sitte HH; Kudlacek O
Neurochem Int; 2014 Jul; 73(100):32-41. PubMed ID: 24296074
[TBL] [Abstract][Full Text] [Related]
8. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.
Maier J; Mayer FP; Luethi D; Holy M; Jäntsch K; Reither H; Hirtler L; Hoener MC; Liechti ME; Pifl C; Brandt SD; Sitte HH
Neuropharmacology; 2018 Aug; 138():282-291. PubMed ID: 29908239
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of methylphenidate-based designer drugs.
Luethi D; Kaeser PJ; Brandt SD; Krähenbühl S; Hoener MC; Liechti ME
Neuropharmacology; 2018 May; 134(Pt A):133-140. PubMed ID: 28823611
[TBL] [Abstract][Full Text] [Related]
10. Recreational use of aminorex and pulmonary hypertension.
Gaine SP; Rubin LJ; Kmetzo JJ; Palevsky HI; Traill TA
Chest; 2000 Nov; 118(5):1496-7. PubMed ID: 11083709
[TBL] [Abstract][Full Text] [Related]
11. Designer psychostimulants: pharmacology and differences.
Iversen L; White M; Treble R
Neuropharmacology; 2014 Dec; 87():59-65. PubMed ID: 24456744
[TBL] [Abstract][Full Text] [Related]
12. DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.
Simmons SJ; Leyrer-Jackson JM; Oliver CF; Hicks C; Muschamp JW; Rawls SM; Olive MF
ACS Chem Neurosci; 2018 Oct; 9(10):2379-2394. PubMed ID: 29714473
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cathinones: an evolving class of new psychoactive substances.
Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional perspectives on interactions between synthetic cathinones and monoamine transporters.
Nguyen VT; Harris AC; Eltit JM
Adv Pharmacol; 2024; 99():83-124. PubMed ID: 38467490
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a recently detected halogenated aminorex derivative: para-fluoro-4-methylaminorex (4'F-4-MAR).
Fabregat-Safont D; Carbón X; Ventura M; Fornís I; Hernández F; Ibáñez M
Sci Rep; 2019 Jun; 9(1):8314. PubMed ID: 31165778
[TBL] [Abstract][Full Text] [Related]
16. Stimulus properties of some analogues of 4-methylaminorex.
Russell BR; Beresford RA; Schmierer DM; McNaughton N; Clark CR
Pharmacol Biochem Behav; 1995; 51(2-3):375-8. PubMed ID: 7667356
[TBL] [Abstract][Full Text] [Related]
17. Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 family.
Mayer FP; Burchardt NV; Decker AM; Partilla JS; Li Y; McLaughlin G; Kavanagh PV; Sandtner W; Blough BE; Brandt SD; Baumann MH; Sitte HH
Neuropharmacology; 2018 May; 134(Pt A):149-157. PubMed ID: 28988906
[TBL] [Abstract][Full Text] [Related]
18. The DARK Side of Total Synthesis: Strategies and Tactics in Psychoactive Drug Production.
Chambers SA; DeSousa JM; Huseman ED; Townsend SD
ACS Chem Neurosci; 2018 Oct; 9(10):2307-2330. PubMed ID: 29342356
[TBL] [Abstract][Full Text] [Related]
19. Cocaine adulteration.
Kudlacek O; Hofmaier T; Luf A; Mayer FP; Stockner T; Nagy C; Holy M; Freissmuth M; Schmid R; Sitte HH
J Chem Neuroanat; 2017 Oct; 83-84():75-81. PubMed ID: 28619473
[TBL] [Abstract][Full Text] [Related]
20. DARK Classics in Chemical Neuroscience: Methamphetamine.
Abbruscato TJ; Trippier PC
ACS Chem Neurosci; 2018 Oct; 9(10):2373-2378. PubMed ID: 29602278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
